http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101648400-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101648400-B1 |
| titleOfInvention | Composition comprising caffeoylglycolic acid methyl ester or 1-O-caffeoylglycerol for preventing or treating inflammatory diseases |
| abstract | The present invention relates to a composition for preventing or treating an inflammatory disease containing caffeoyl glycolic acid methyl ester or 1-O-caffeoyl glycerol derived from a water extract, wherein the caffeoyl glycolic acid methyl ester or 1-O-caffe Oleglycerol activates HO-1 (heme oxygenase-1) through the induction of transcription factor Nrf2 to inhibit the expression of inflammatory cytokines and various inflammatory factors and thereby to prevent inflammatory bowel disease, atherosclerosis, inflammatory collagen vascular disease, It can be easily used as a therapeutic agent or a health functional food for various diseases such as nephritis, inflammatory skin disease, sarcoidosis, retinitis, gastritis, hepatitis, enteritis, arthritis, tonsillitis, sore throat, bronchitis, pneumonia, pancreatitis, sepsis and nephritis. |
| priorityDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 340.